{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:47:19Z","timestamp":1792014439358,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ajic.2015.05.033","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T21:03:18Z","timestamp":1436216598000},"page":"e53-e59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance"],"prefix":"10.1016","volume":"43","author":[{"given":"J.J.","family":"Parienti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Lucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Armand-Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Cattoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2015.05.033_bib1","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajic.2015.05.033_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dks065","article-title":"Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis","volume":"67","author":"Rottier","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1047-2797(02)00272-7","article-title":"Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality","volume":"13","author":"Foxman","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.033_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajic.2015.05.033_bib7","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/CCM.0b013e31821b827c","article-title":"Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality","volume":"39","author":"Zahar","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajic.2015.05.033_bib8","first-page":"114","article-title":"Prospective cohort study of acute pyelonephritis in adults: safety of triage towards home based oral antimicrobial treatment","volume":"60","author":"van Nieuwkoop","year":"2010","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ajic.2015.05.033_bib9","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib10","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00009-11","article-title":"Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system","volume":"55","author":"Tumbarello","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/JCM.01902-10","article-title":"Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia","volume":"49","author":"Lefort","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajic.2015.05.033_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkm193","article-title":"Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Vidal","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib13","doi-asserted-by":"crossref","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","article-title":"Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country","volume":"8","author":"S\u00f8raas","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ajic.2015.05.033_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.diagmicrobio.2012.05.024","volume":"74","author":"Hoban","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib15","first-page":"478","article-title":"Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections","volume":"64","author":"Aguilar-Duran","year":"2012","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ajic.2015.05.033_bib16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","article-title":"Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011","volume":"35","author":"Bouchillon","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajic.2015.05.033_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib18","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s10096-012-1672-0","article-title":"Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients","volume":"31","author":"G\u00fcndo\u011fdu","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u03b2-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.ajic.2015.05.033_bib20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/671740","article-title":"Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009","volume":"34","author":"Zilberberg","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.033_bib21","first-page":"30","article-title":"Pyelonephritis in pregnancy. How adequate is empirical treatment?","volume":"26","author":"Artero","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ajic.2015.05.033_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinte.165.12.1375","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection","volume":"165","author":"Hyle","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajic.2015.05.033_bib24","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.06212-11","article-title":"Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high","volume":"56","author":"Jeon","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib25","first-page":"159","article-title":"Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis","volume":"62","author":"Lee","year":"2011","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ajic.2015.05.033_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/mdr.2013.0075","article-title":"Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone","volume":"20","author":"Lee","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ajic.2015.05.033_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1086\/322603","article-title":"Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis","volume":"33","author":"Le","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-12-245","article-title":"Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study","volume":"12","author":"Peralta","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s15010-013-0441-z","article-title":"Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.ajic.2015.05.033_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1586\/eri.13.4","article-title":"Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence","volume":"11","author":"Tansarli","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ajic.2015.05.033_bib31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/CCM.0000000000001028","article-title":"The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study","volume":"43","author":"Dautzenberg","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajic.2015.05.033_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/aje\/kwt017","article-title":"A\u00a0modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization","volume":"178","author":"Spicknall","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.033_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s15010-012-0359-x","article-title":"Why is antimicrobial de-escalation under-prescribed for urinary tract infections?","volume":"41","author":"Duch\u00eane","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.ajic.2015.05.033_bib34","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/AAC.00238-13","article-title":"Relative fecal abundance of extended-spectrum-\u03b2-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women","volume":"57","author":"Rupp\u00e9","year":"2013","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajic.2012.05.015","article-title":"Duration of colonization by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae after hospital discharge","volume":"41","author":"Birgand","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2015.05.033_bib36","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/657138","article-title":"Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes","volume":"31","author":"Hyle","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.033_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A\u00a0multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.033_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2047-2994-3-9","article-title":"Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria","volume":"3","author":"Kassakian","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2015.05.033_bib39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","article-title":"Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011","volume":"35","author":"Bouchillon","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajic.2015.05.033_bib40","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.ajic.2015.05.033_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/CCM.0b013e3181fa41a7","article-title":"Inappropriate antibiotic therapy in gram-negative sepsis increases hospital length of stay","volume":"39","author":"Shorr","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajic.2015.05.033_bib42","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.01823-12","article-title":"Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients","volume":"57","author":"Armand-Lef\u00e8vre","year":"2013","journal-title":"Antimicrobial Agents Chemother"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655315006227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655315006227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:44:14Z","timestamp":1759297454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655315006227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0196655315006227"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2015.05.033","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2015.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}